Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Fed State Budgetary Inst "N.N. Blokhin Med Center of Oncology" MHRF-Chemotherapy #2 (Site 2211)

Moscow, Moscow 115478, RussiaNot linked to an institution yet

1running trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Ovarian cancer

Running trials

Active, not recruiting
Pembrolizumab/Placebo Plus Paclitaxel With or Without Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer (MK-3475-B96/KEYNOTE-B96/ENGOT-ov65).
NCT05116189· Phase 3· Merck Sharp & Dohme LLC· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Under construction, not live – Fed State Budgetary Inst "N.N. Blokhin Med Center of Oncology" MHRF-Chemotherapy #2 (Site 2211): trial site – Frontlight Research